Lumina Fund Management LLC Arcus Biosciences, Inc. Transaction History

Lumina Fund Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$8.95 - $12.49 $179,000 - $249,800	-20,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.95 $32,640 - $44,850	3,000 Added 17.65%	20,000 $279,000
Q2 2018 Aug 13, 2018	BUY	$12.24 - $17.05 $176,868 - $246,372	14,450 Added 566.67%	17,000 $208,000
Q1 2018 May 14, 2018	BUY	$15.44 - $17.71 $39,372 - $45,160	2,550 New	2,550 $39,000

186

49.2M

204K

149K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.02B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Lumina Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lumina Fund Management LLC with notifications on news.